INNOVIVA INC(NASDAQ:INVA) stock News

INVA Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Benzinga - Mentions: CSCO MANH TRIP SHOP

This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

a month ago - By: Innoviva Specialty Therapeutics, Inc.

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

a month ago - By: Innoviva, Inc.

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults

3 months ago - By: Benzinga

Rep. George Whitesides Has Sold Up to $5.18M Worth Of Innoviva Stock: Here's What You Should Know

2 months ago - By: Innoviva, Inc.

Innoviva to Participate in Upcoming Investor Conferences

2 months ago - By: Innoviva Specialty Therapeutics, Inc.

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections

2 months ago - By: Yahoo Finance - Mentions: MSFT AMZN

Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling

2 months ago - By: Innoviva, Inc.

Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress

4 months ago - By: Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva

5 months ago - By: Innoviva, Inc.

Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference

a year ago - By: BusinessInsider

INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024

a year ago - By: BusinessInsider

INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024

a year ago - By: InvestorPlace

INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024

5 months ago - By: Innoviva, Inc.

Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress

5 months ago - By: Innoviva, Inc.

Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

7 months ago - By: Innoviva, Inc.

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)

8 months ago - By: Innoviva, Inc.

Innoviva to Participate in the Citi 2024 Global Healthcare Conference

8 months ago - By: Innoviva, Inc.

Innoviva to Participate in the UBS Global Healthcare Conference

9 months ago - By: Innoviva, Inc.

Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress

11 months ago - By: Innoviva, Inc.

Innoviva to Participate in Upcoming Investor Conferences

a year ago - By: InvestorPlace

INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024

a year ago - By: Innoviva, Inc.

Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress

a year ago - By: InvestorPlace - Mentions: SEM CARS GSK

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024

a year ago - By: InvestorPlace - Mentions: SILV GSL ARMP

3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge

a year ago - By: Innoviva, Inc.

Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

a year ago - By: InvestorPlace - Mentions: IMAX LSPD

3 Under-$20 Stocks That Could Make You a Fortune

a year ago - By: Innoviva, Inc.

Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress

a year ago - By: Innoviva, Inc.

Innoviva to Participate in the BofA Securities Health Care Conference

a year ago - By: Innoviva Specialty Therapeutics

INNOVIVA INC (INVA) Stock News

INVA Latest News, Press Relases and Analysis

This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults

Rep. George Whitesides Has Sold Up to $5.18M Worth Of Innoviva Stock: Here's What You Should Know

Innoviva to Participate in Upcoming Investor Conferences

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections

Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling

Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress

Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva

Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference

INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024

INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024

INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024

Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress

Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)

Innoviva to Participate in the Citi 2024 Global Healthcare Conference

Innoviva to Participate in the UBS Global Healthcare Conference

Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress

Innoviva to Participate in Upcoming Investor Conferences

INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024

Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024

3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge

Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

3 Under-$20 Stocks That Could Make You a Fortune

Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress

Innoviva to Participate in the BofA Securities Health Care Conference

Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024